Page last updated: 2024-09-05

technetium tc 99m pentetate and Spinal Cord Neoplasms

technetium tc 99m pentetate has been researched along with Spinal Cord Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colandrea, J; Copeland, C; Dedrick, RL; DeVroom, HL; Greenfield, L; Groves, ES; Houston, LL; Katz, D; Laske, DW; Muraszko, KM; Oldfield, EH; Simon, TR; Sung, C; Youle, RJ	1

Trials

1 trial(s) available for technetium tc 99m pentetate and Spinal Cord Neoplasms

Article	Year
Intraventricular immunotoxin therapy for leptomeningeal neoplasia. Neurosurgery, 1997, Volume: 41, Issue:5 Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cerebral Ventricles; Female; Half-Life; Humans; Immunotoxins; Infusions, Parenteral; Melanoma; Meningeal Neoplasms; Metabolic Clearance Rate; Mice; Middle Aged; Pilot Projects; Receptors, Transferrin; Recombinant Proteins; Ricin; Spinal Cord Neoplasms; Technetium Tc 99m Pentetate	1997

Article

Year

Intraventricular immunotoxin therapy for leptomeningeal neoplasia.

Neurosurgery, 1997, Volume: 41, Issue:5

Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cerebral Ventricles; Female; Half-Life; Humans; Immunotoxins; Infusions, Parenteral; Melanoma; Meningeal Neoplasms; Metabolic Clearance Rate; Mice; Middle Aged; Pilot Projects; Receptors, Transferrin; Recombinant Proteins; Ricin; Spinal Cord Neoplasms; Technetium Tc 99m Pentetate

1997